XPH

Fund Description
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible before expenses the total return performance of the S&P Pharmaceuticals Select Industry Index (ticker: SPSIPHTR).
Fund Profile
Fund Name SPDR S&P Pharmaceuticals ETF
Fund Exchange Ticker XPH
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A7220
Net Expense Ratio 0.35 %
Fund Inception Date 19 June 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Pharmaceuticals Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 28 May 2020
Asset Under Management 248.67 Million (USD)
1 Month Total Return 4.37 %
Year To Date Return -5.11 %
1 Year Total Return 15.84 %
3 Year Annualized Total Return 1.88 %
NAV 43.2452
Share Outstanding 5,750,270
Top 10 Holdings (28 May 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
HORIZON THERAPEUTICS PLC HZNP EQUI 0.0676202300
CATALENT INC CTLT EQUI 0.0621120100
ELI LILLY & CO LLY EQUI 0.0578608800
Zoetis Inc. Class A ZTS EQUI 0.0517991500
NEKTAR THERAPEUTICS NKTR EQUI 0.0487390000
JOHNSON & JOHNSON JNJ EQUI 0.0485209900
PERRIGO CO PLC PRGO EQUI 0.0476284600
PFIZER INC PFE EQUI 0.0464931300
BRISTOL-MYERS SQUIBB CO BMY EQUI 0.0437435200
MYLAN NV MYL EQUI 0.0420670700